tradingkey.logo

KORU Medical Systems Inc

KRMD
6.230USD
-0.250-3.86%
Close 12/26, 16:00ETQuotes delayed by 15 min
288.41MMarket Cap
LossP/E TTM

KORU Medical Systems Inc

6.230
-0.250-3.86%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of KORU Medical Systems Inc

Currency: USD Updated: 2025-12-26

Key Insights

KORU Medical Systems Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 49/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.65.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

KORU Medical Systems Inc's Score

Industry at a Glance

Industry Ranking
49 / 207
Overall Ranking
150 / 4563
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
5.650
Target Price
-1.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

KORU Medical Systems Inc Highlights

StrengthsRisks
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.61% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.65M.
Undervalued
The company’s latest PE is -77.22, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 25.43M shares, decreasing 0.92% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 2.15M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.08.

Financial Health

Currency: USD Updated: 2025-12-26

The current financial score of KORU Medical Systems Inc is 8.00, ranking 57/207 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 10.40M, representing a year-over-year increase of 27.17%, while its net profit experienced a year-over-year increase of 50.79%.

Score

Industry at a Glance

Previous score
8.00
Change
0

Financials

9.12

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.60

Operational Efficiency

8.17

Growth Potential

8.78

Shareholder Returns

7.35

KORU Medical Systems Inc's Company Valuation

Currency: USD Updated: 2025-12-26

The current valuation score of KORU Medical Systems Inc is 7.24, ranking 109/207 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -77.22, which is -91.23% below the recent high of -6.77 and -4.65% above the recent low of -80.81.

Score

Industry at a Glance

Previous score
7.24
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 49/207
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2025-12-26

The current earnings forecast score of KORU Medical Systems Inc is 7.60, ranking 123/207 in the Healthcare Equipment & Supplies industry. The average price target for KORU Medical Systems Inc is 6.00, with a high of 7.00 and a low of 4.00.

Score

Industry at a Glance

Previous score
7.60
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
5.650
Target Price
-1.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

112
Total
6
Median
9
Average
Company name
Ratings
Analysts
KORU Medical Systems Inc
KRMD
5
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-12-26

The current price momentum score of KORU Medical Systems Inc is 9.20, ranking 17/207 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 6.83 and the support level at 5.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.54
Change
-0.34

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.023
Buy
RSI(14)
65.755
Neutral
STOCH(KDJ)(9,3,3)
76.627
Neutral
ATR(14)
0.337
Low Volatility
CCI(14)
121.098
Buy
Williams %R
31.255
Buy
TRIX(12,20)
1.031
Sell
StochRSI(14)
12.344
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
6.220
Buy
MA10
5.972
Buy
MA20
5.867
Buy
MA50
4.891
Buy
MA100
4.470
Buy
MA200
3.729
Buy

Institutional Confidence

Currency: USD Updated: 2025-12-26

The current institutional shareholding score of KORU Medical Systems Inc is 5.00, ranking 111/207 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 54.99%, representing a quarter-over-quarter decrease of 10.41%. The largest institutional shareholder is The Vanguard, holding a total of 2.15M shares, representing 4.63% of shares outstanding, with 21.16% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Horton Capital Management LLC
5.87M
-0.27%
First Light Asset Management, LLC
4.68M
-0.69%
Topline Capital Management, LLC
3.61M
-5.57%
The Vanguard Group, Inc.
Star Investors
2.09M
+18.23%
Tharby (Linda M)
2.09M
+16.34%
BlackRock Institutional Trust Company, N.A.
1.67M
+818.20%
Geode Capital Management, L.L.C.
997.15K
+101.33%
Meros Investment Management, LP
850.39K
+13.91%
Acuitas Investments LLC
402.49K
+517.17%
1
2

Risk Assessment

Currency: USD Updated: 2025-12-26

The current risk assessment score of KORU Medical Systems Inc is 3.85, ranking 117/207 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
3.85
Change
0
Beta vs S&P 500 index
0.50
VaR
+5.44%
240-Day Maximum Drawdown
+57.96%
240-Day Volatility
+70.30%

Return

Best Daily Return
60 days
+15.08%
120 days
+18.71%
5 years
+25.18%
Worst Daily Return
60 days
-5.13%
120 days
-8.70%
5 years
-18.29%
Sharpe Ratio
60 days
+3.75
120 days
+2.15
5 years
+0.46

Risk Assessment

Maximum Drawdown
240 days
+57.96%
3 years
+57.96%
5 years
+59.29%
Return-to-Drawdown Ratio
240 days
+1.00
3 years
+0.36
5 years
+0.22
Skewness
240 days
+0.96
3 years
+0.77
5 years
+0.79

Volatility

Realised Volatility
240 days
+70.30%
5 years
+73.16%
Standardised True Range
240 days
+3.57%
5 years
+3.11%
Downside Risk-Adjusted Return
120 days
+446.47%
240 days
+446.47%
Maximum Daily Upside Volatility
60 days
+51.55%
Maximum Daily Downside Volatility
60 days
+31.01%

Liquidity

Average Turnover Rate
60 days
+0.51%
120 days
+0.41%
5 years
--
Turnover Deviation
20 days
-8.19%
60 days
+73.07%
120 days
+41.67%

Peer Comparison

Healthcare Equipment & Supplies
KORU Medical Systems Inc
KORU Medical Systems Inc
KRMD
7.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
Edwards Lifesciences Corp
EW
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
Artivion Inc
AORT
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
Tactile Systems Technology Inc
TCMD
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more

FAQs

How does TradingKey generate the Stock Score of KORU Medical Systems Inc?

The TradingKey Stock Score provides a comprehensive assessment of KORU Medical Systems Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of KORU Medical Systems Inc’s performance and outlook.

How do we generate the financial health score of KORU Medical Systems Inc?

To generate the financial health score of KORU Medical Systems Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects KORU Medical Systems Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of KORU Medical Systems Inc.

How do we generate the company valuation score of KORU Medical Systems Inc?

To generate the company valuation score of KORU Medical Systems Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare KORU Medical Systems Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of KORU Medical Systems Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of KORU Medical Systems Inc.

How do we generate the earnings forecast score of KORU Medical Systems Inc?

To calculate the earnings forecast score of KORU Medical Systems Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on KORU Medical Systems Inc’s future.

How do we generate the price momentum score of KORU Medical Systems Inc?

When generating the price momentum score for KORU Medical Systems Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of KORU Medical Systems Inc’s prices. A higher score indicates a more stable short-term price trend for KORU Medical Systems Inc.

How do we generate the institutional confidence score of KORU Medical Systems Inc?

To generate the institutional confidence score of KORU Medical Systems Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about KORU Medical Systems Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of KORU Medical Systems Inc.

How do we generate the risk management score of KORU Medical Systems Inc?

To assess the risk management score of KORU Medical Systems Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of KORU Medical Systems Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of KORU Medical Systems Inc.
KeyAI